Showing results (491-500 of 782) with videos related to

Sort By:
Pageof 79
Blood|December 14, 2002
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arraysDharminder Chauhan, Guilan Li, Daniel Auclair, et al.
Blood|July 2, 2002
Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myelomaChristian Brander, Noopur Raje, Paula G O'Connor, et al.
Blood|August 21, 2004
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.
British Journal of Haematology|September 17, 2013
Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myelomaYoon Joong Kang, Wanyong Zeng, Weihua Song, et al.
Oncogene|February 22, 2002
Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arraysDharminder Chauhan, Daniel Auclair, Elisabeth K Robinson, et al.
Blood|October 13, 2006
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)Dharminder Chauhan, Paola Neri, Mugdha Velankar, et al.
Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironmentToshiaki Hayashi, Teru Hideshima, Aaron N Nguyen, et al.
Blood Cancer Journal|November 11, 2018
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world settingPaul G Richardson, Jesus F San Miguel, Philippe Moreau, et al.
Blood|February 1, 2012
Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune functionDouglas W McMillin, Jake Delmore, Joseph M Negri, et al.
Pageof 79